Dermatofibrosarcoma protuberans of the vulva: A clinicopathologic and immunohistochemical study of 13 cases

American Journal of Surgical Pathology

Volumn 34, Issue 3, 2010, Pages 393-400

  Edelweiss, Marcia ^a   Malpica, Anais ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Dermatofibrosarcoma protuberans; Fibrosarcomatous transformation; Gleevec; Imatinib; Immunohistochemistry; Sarcoma; Vulva

Indexed keywords

TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CHEMISTRY; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; FEMALE; GYNECOLOGIC SURGERY; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; REOPERATION; SKIN TUMOR; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; VULVA TUMOR;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY, ADJUVANT; REOPERATION; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 77649204273     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181cf7fc1     Document Type: Article

References (47)

1. Aartsen EJ, Albus-Lutter CE. Vulvar sarcoma: clinical implications. Eur J Obstet Gynecol Reprod Biol. 1994;56:181-189.
2. Abbott JJ, Oliveira AM, Nascimento AG. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Am J Surg Pathol. 2006;30:436-443.
3. Agress R, Figge DC, Tamimi H, et al. Dermatofibrosarcoma protuberans of the vulva. Gynecol Oncol. 1983;16:288-291.
4. Alverez-Canas MC, Mayorga M, Fernandez F, et al. Dermatofibrosarcoma protuberans of the vulva: clinico-pathological, immunohistochemical and flow cytometric study of a case. Acta Obstet Gynecol Scand. 1996;75:82-85.
5. Bague S, Folpe AL. Dermatofibrosarcoma protuberans presenting as a subcutaneous mass: a clinicopathological study of 15 cases with exclusive or near-exclusive subcutaneous involvement. Am J Dermatopathol. 2008;30:327-332.
6. Barnhill DR, Boling R, Nobles W, et al. Vulvar dermatofibrosarcoma protuberans. Gynecol Oncol. 1988;30:149-152.
7. Biedrzycki O, Singh N, Habeeb H, et al. Solitary fibrous tumor of the female genital tract. A case report and review of the literature. Int J Gynecol Pathol. 2007;26:259-264.
8. Bock JE, Andreasson B, Thorn A, et al. Dermatofibrosarcoma protuberans of the vulva. Gynecol Oncol. 1985;20:129-135.
9. Bowne WB, Antonescu CR, Leung DH, et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000;88:2711-2720.
10. Chetty R. Dermatofibrosarcoma protuberans of the vulva. Int J Gynecol Cancer. 1997;7:461-465.
11. Connelly JH, Evans HL. Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas. Am J Surg Pathol. 1992;16:921-925.
12. Davos I, Abell MR. Soft tissue sarcomas of vulva. Gynecol Oncol. 1976;4:70-86.
13. Fiore M, Miceli R, Mussi C, et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol. 2005;23:7669-7675.
14. Fisher C. Soft tissue tumours. In: LeBoit PE BG, Weedon D, Sarasain A, eds. World Health Organization Classification of Tumours Pathology and Genetics of Skin Tumours. Lyon: IARC Press; 2006.
15. Garcia C, Clark RE, Buchanan M. Dermatofibrosarcoma protuberans. Int J Dermatol. 1996;35:867-871.
16. Ghorbani RP, Malpica A, Ayala AG. Dermatofibrosarcoma protuberans of the vulva: clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature. Int J Gynecol Pathol. 1999;18:366-373.
17. Gokden N, Dehner LP, Zhu X, et al. Dermatofibrosarcoma protuberans of the vulva and groin: detection of COL1A1-PDGFB fusion transcripts by RT-PCR. J Cutan Pathol. 2003;30:190-195.
18. Goldblum JR, Reith JD, Weiss SW. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up. Am J Surg Pathol. 2000;24:1125-1130.
19. Hoang MP, Selim MA, Bentley RC, et al. CD34 expression in desmoplastic melanoma. J Cutan Pathol. 2001;28:508-512.
20. Karlen JR, Johnson K, Kashkari S. Dermatofibrosarcoma protuberans of the vulva. A case report. J Reprod Med. 1996;41:267-269.
21. Kholova I, Ryska A, Dedic K. Composite tumor consisting of dermatofibrosarcoma protuberans and giant cell fibroblastoma associated with intratumoral endometriosis. Report of a case. Pathol Res Pract. 2001;197:263-267; discussion 269-270.
22. Kovarik CL, Hsu MY, Cockerell CJ. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm. J Cutan Pathol. 2004;31:492-496.
23. Labonte S, Hanna W, Bandarchi-Chamkhaleh B. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma. J Cutan Pathol. 2007;34:857-860.
24. Lambrou NC, Mirhashemi R, Wolfson A, et al. Malignant peripheral nerve sheath tumor of the vulva: a multimodal treatment approach. Gynecol Oncol. 2002;85:365-371.
25. Leake JF, Buscema J, Cho KR, et al. Dermatofibrosarcoma protuberans of the vulva. Gynecol Oncol. 1991;41:245-249.
26. Llatjos R F-FM, Diaz-Cascajo C, Ariza A. Palisading and verocay body-prominent dermatofibrosarcoma protuberans: a report of three cases. Histopathol. 2000;37:452-455.
27. Maglione M, Tricarico O, Calandria L. Malignant peripheral nerve sheath tumor of the vulva. A case report. J Reprod Med. 2002; 47:721-724.
28. McArthur GA. Dermatofibrosarcoma protuberans: a surgical disease with a molecular savior. Curr Opin Oncol. 2006;18:341-346.
29. McArthur GA. Molecular targeting of dermatofibrosarcoma protuberans: a new approach to a surgical disease. J Natl Compr Canc Netw. 2007;5:557-562.
30. McCarthy S, Crotty K, Scolyer R. Desmoplastic melanoma and desmoplastic neurotropic melanoma. In: LeBoit P, Burg G, Weedon D, et al, eds. World Health Organization Classification of Tumours Pathology and Genetics of Skin Tumours. Lyon: IARC Press; 2006.
31. Mentzel T, Beham A, Katenkamp D, et al. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol. 1998;22: 576-587.
32. Moodley M, Moodley J. Dermatofibrosarcoma protuberans of the vulva: a case report and review of the literature. Gynecol Oncol. 2000;78:74-75.
33. Mulvany NJ, Sykes P. Desmoplastic melanoma of the vulva. Pathology. 1997;29:241-245.
34. Nielsen G, Rosenberg A, Koerner F, et al. Smooth-muscle tumors of the vulva. A clinicopathological study of 25 cases and review of the literature. Am J Surg Pathol. 1996;20:779-793.
35. Nirenberg A, Ostor AG, Slavin J, et al. Primary vulvar sarcomas. Int J Gynecol Pathol. 1995;14:55-62.
36. Ohlinger R, Kuhl A, Schwesinger G, et al. Dermatofibrosarcoma protuberans of the vulva. Acta Obstet Gynecol Scand. 2004;83: 685-686.
37. Panidis D, Rousso D, Achparaki A, et al. Recurrence of dermatofibrosarcoma protuberans of the vulva. A clinical, histological, and ultrastructural study. Eur J Gynaecol Oncol. 1993;14: 182-186.
38. Reimann JD, Fletcher CD. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases. Am J Surg Pathol. 2007;31:1371-1377.
39. Soergel TM, Doering DL, O'Connor D. Metastatic dermatofibrosarcoma protuberans of the vulva. Gynecol Oncol. 1998;71:320-324.
40. Soltan MH. Dermatofibrosarcoma protuberans of the vulva. Case report. Br J Obstet Gynaecol. 1981;88:203-205.
41. Vanni R, Faa G, Dettori T, et al. A case of dermatofibrosarcoma protuberans of the vulva with a COL1A1/PDGFB fusion identical to a case of giant cell fibroblastoma. Virchows Arch. 2000;437: 95-100.
42. Weiss S, Goldblum J. Malignant tumors of the peripheral nerves. In: Enzinger F, Weiss S, eds. Enzinger & Weiss's Soft Tissue Tumors. China: Mosby, Elsevier, Inc; 2008.
43. Weiss S, Goldblum J. Soft tissue tumors of intermediate malignancy of uncertain type. In: Enzinger F, Weiss S, eds. Enzinger & Weiss's Soft Tissue Tumors. China: Mosby, Elsevier, Inc; 2008.
44. Weiss SW, Goldblum JR. Benign fibrohistiocytic tumors. In: Enzinger FM, Weiss SW, eds. Enzinger & Weiss's Soft Tissue Tumors. China: Mosby, Elsevier, Inc; 2008.
45. Weyers W, Mentzel T, Kasper RC, et al. Soft tissue tumours: fibrous, fibrohistiocytic and histocytic tumours. In: LeBoit PE BG, Weedon D, Sarasain A, ed. World Health Organization Classification of Tumours Pathology and Genetics of Skin Tumours. Lyon: IARC Press; 2006:254-262.
46. Wick MR, Ritter JH, Lind AC, et al. The pathological distinction between "deep penetrating" dermatofibroma and dermatofibrosarcoma protuberans. Semin Cutan Med Surg. 1999;18:91-98.
47. Wrotnowski U, Cooper PH, Shmookler BM. Fibrosarcomatous change in dermatofibrosarcoma protuberans. Am J Surg Pathol. 1988;12:287-293.